FDA’s Creation Of Pharmacologic Classes Is Mostly Reviewers’ Responsibility
This article was originally published in The Pink Sheet Daily
Executive Summary
A new chapter of CDER’s Manual of Policies and Procedures says reviewers should consider EPC text phrases in the IND stage as pharmacology information is submitted.